Please select the option that best describes you:

How do you approach a patient with metastatic urothelial carcinoma who has progressed on maintenance avelumab?  

Assuming no actionable mutations?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Veterans Administration Health Care Center
I think Dr. @Petros Grivas makes good points, but ...
Sign in or Register to read more